April 29, 2008 - Cardium Therapeutics and its operating unit InnerCool Therapies said today that InnerCool’s endovascular Celsius Control System was featured on Science Channel’s “Cool Stuff: How It Works.”

The segment (episode 5) aired April 25, 2008, and is scheduled to be rebroadcast at 8:30 p.m. and 11:30 p.m. (ET/PT) on Friday, May 9.

April 29, 2008 - HealthEast Care System publicized The National Brain Aneurysm Center and the www.brainaneurysmcenter.org Web site, formerly the HealthEast Neurovascular Institute, focusing on complex neurovascular conditions such as aneurysm, stroke, vascular malformations, brain tumors and more.

April 29, 2008 - Nihon Kohden America Inc. said its Prefense Early Detection and Notification System received 510(k) clearance from the FDA, paving the way for its release to customers.

Prefense is designed to protect hospital patients from medical harm and enhance the efficiency of rapid response teams. Prefense is unique as it allows hospital patients to freely ambulate while measuring heart rate, blood pressure, oxygen saturation and respiration - four of the seven critical parameters that trigger a rapid response team.

April 28, 2008 - CVRx introduced a new device for high blood pressure engineered to treat hypertension patients whose conditions are not controlled by drugs, and aims to reduce systolic blood pressure.

Rheos Hypertension (HT) Therapy, which is now in clinical trials, is an implantable device and uses the body's natural blood pressure sensor (the baroreflex) to reduce blood pressure. Early hypertension clinical trial results showed a 39 mmHg reduction in systolic blood pressure at one year of use.

InfraReDx Inc. developed the LipiScan Coronary Imaging System that is intended to characterize fatty deposits in coronary vessel walls using near infrared diffuse spectroscopy.

Medtronic's Defender embolic protection filter, available in Europe, is a device designed to get rid of emboli that can occur during a variety of stenting procedures.

Nihon Kohden America Inc. provides a Prefense Early Detection and Notification System, an early detection and notification system, has received 510K clearance from the FDA, paving the way for immediate release to customers.

Prefense is designed to protect hospital patients from medical harm and enhance the efficiency of Rapid Response Teams. Prefense is unique as it allows hospital patients to freely ambulate while measuring heart rate, blood pressure, oxygen saturation and respiration - four of the seven critical parameters that trigger a rapid response team.

The VeinViewer by Luminetx is a vascular imaging system that allows physicians, nurses and other healthcare professionals to clearly see accessible vasculature (or lack thereof) in real time. The company will highlight the product at the product at the American Association of Critical Care Nurses Conference May 6-7 in Chicago.

April 28, 2008 – A study of clinical trials involving artificial blood substitutes has shown they can cause an increased in risk of death and heart attacks, according to an article this week in the Journal of the American Medical Association.

April 28, 2008 - Terumo Heart will present data on its DuraHeart LVAS, a circulatory support device intended to provide cardiac support for patients who are at risk of death due to end-stage left ventricular failure, which indicates the device provides safe and reliable long-term circulatory support with improved survival.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now